LUCA Science Inc. (Graphic: Business Wire) TOKYO–( BUSINESS WIRE )–LUCA Science, a company developing functional mitochondria as therapeutic agents, an emerging platform to treat damaged tissues and organs, today announced the closing of a $9.8 million Series A financing. The funding round was led by Axil Capital Partners. Additional […]
Click here to view original web page at www.businesswire.com